Tryptophan-Kynurenine Pathway

The Core Problem

Tryptophan is the precursor for two competing pathways:

1. Serotonin pathway → serotonin → melatonin (mood, sleep, social behaviour, impulse control)
2. Kynurenine pathway → kynurenine → quinolinic acid (neurotoxic) or kynurenic acid (neuroprotective)

When inflammation is present, the enzyme indoleamine 2,3-dioxygenase (IDO) is activated, shunting tryptophan away from serotonin and towards kynurenine. This is the inflammatory tryptophan steal.

The Pathway

flowchart TD
    classDef source fill:#d2b4de,stroke:#7d3c98,color:#1a0422
    classDef protect fill:#58d68d,stroke:#1e8449,color:#0a1f12
    classDef danger fill:#f1948a,stroke:#c0392b,color:#1a0505

    A[Tryptophan]:::source --> B[Kynurenine via IDO]
    A --> C[5-HTP then Serotonin via TPH]:::protect
    C --> D[Melatonin]
    B --> E[3-Hydroxykynurenine - neurotoxic]
    B --> F[Kynurenic acid - neuroprotective]:::protect
    E --> G[Quinolinic acid - NMDA agonist]:::danger
    G --> H[Glutamate excess - repetitive behaviours]

Evidence in Autism

• IDO activation found in 58.7% of individuals with ASD (PMID: 38071324)
• IDO activation was associated with normoserotonemia — suggesting it masks what would otherwise be hyperserotonemia
• If IDO activation weren't present, hyperserotonemia could be present in ~94% of ASD individuals
• Increased kynurenine:tryptophan ratio documented in autistic adults and their first-degree relatives (Cambridge Core, CNS Spectrums)
• Decreased tryptophan metabolism overall in ASD patients (Mol Autism 2013;4:16)
• Quinolinic acid (downstream neurotoxic metabolite) is elevated → enhances glutamatergic neurotransmission → may drive repetitive behaviours

Key Citations

• Gevi F et al. Mol Autism 2013;4:16 — decreased tryptophan metabolism in autism
• Bryn V et al. PMID: 26497015 — altered kynurenine pathway metabolism, implications for glutamatergic activity
• Tryptophan metabolism review: Mol Neurobiol 2025 (Springer)

Iron's Role in This Pathway

Direct Effects

• IDO is a heme-containing enzyme — it requires iron for catalytic activity
• In iron overload, IDO may be more readily activated → greater tryptophan steal
• Iron-mediated oxidative stress → chronic low-grade inflammation → IDO activation
• This creates a feed-forward loop: iron overload → inflammation → IDO activation → serotonin depletion + glutamate excess

Indirect Effects

• Iron overload → microglial activation → neuroinflammation → IDO activation in CNS
• Iron overload → gut dysbiosis → systemic inflammation → peripheral IDO activation
• NTBI (non-transferrin bound iron) → direct oxidative damage → inflammatory cytokine release → IDO

Relevance for Anthony

His TSAT of 60% and ferritin of 380 represent a chronic inflammatory stimulus that may be:

1. Sustaining IDO activation
2. Depleting tryptophan away from serotonin
3. Increasing quinolinic acid → driving glutamate excitotoxicity → worsening TTM
4. Impairing melatonin production → disrupting sleep → worsening ADHD/autism symptoms

Phlebotomy could interrupt this entire cascade at the source.

Therapeutic Implications

Open Questions

• What is Anthony's tryptophan:kynurenine ratio? (testable via blood/urine metabolomics)
• Does his iron overload correlate with elevated inflammatory markers (hsCRP, IL-6)?
• Would phlebotomy measurably shift serotonin:kynurenine balance?

Verified Academic Citations

Last verified: 2026-03-22

Kynurenine Pathway in Autism — Systematic Reviews and Meta-Analyses

1. Almulla AF, Thipakorn Y, Tunvirachaisakul C, et al. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder: a systematic review and meta-analysis. Autism Res. 2024. PMID: 37909397 | DOI: 10.1002/aur.3044

   • Meta-analysis confirming activated immune-inflammatory and nitro-oxidative pathways in ASD are accompanied by tryptophan depletion, increased competing amino acids, and kynurenine pathway activation.

2. Santana-Coelho D. Does the kynurenine pathway play a pathogenic role in autism spectrum disorder? Brain Behav Immun Health. 2024. PMID: 39263315 | DOI: 10.1016/j.bbih.2024.100839

   • Reviews evidence that inflammation-driven kynurenine pathway activation contributes to ASD pathogenesis; discusses inhibition of IDO as potential therapeutic strategy.

IDO Activation and Serotonin in Autism

3. Launay JM, Delorme R, Pagan C, et al. Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD+ production, and AhR activation in autism spectrum disorder. Transl Psychiatry. 2023. PMID: 38071324 | DOI: 10.1038/s41398-023-02687-w

   • Key finding: IDO activation found in 58.7% of ASD individuals; IDO activation masks what would otherwise be hyperserotonemia in ~94% of ASD; links kynurenine pathway to NAD+ production and aryl hydrocarbon receptor activation.

4. Ishikawa M, Yamamoto Y, Wulaer B, et al. Indoleamine 2,3-dioxygenase 2 deficiency associates with autism-like behavior via dopaminergic neuronal dysfunction. FEBS J. 2024. PMID: 38037233 | DOI: 10.1111/febs.17019

   • IDO2 knockout mice display stereotyped behaviour, restricted interest, and social deficits (ASD traits); mechanism involves dopaminergic neuronal dysfunction — links kynurenine pathway to dopamine system.

Gut Microbiota Regulation of Tryptophan Metabolism

5. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018. PMID: 29902437 | DOI: 10.1016/j.chom.2018.05.003
   • Seminal review: gut bacteria directly modulate tryptophan availability and metabolism through three major pathways — serotonin, kynurenine, and indole; dysbiosis shifts balance towards kynurenine.

Iron, Gut Dysbiosis, and Cognitive Function

6. Suparan K, Trirattanapa K, Piriyakhuntorn P, et al. Exploring alterations of gut/blood microbes in addressing iron overload-induced gut dysbiosis and cognitive impairment in thalassemia patients. Sci Rep. 2024. PMID: 39438708 | DOI: 10.1038/s41598-024-76684-4

   • Iron overload causes gut dysbiosis and cognitive impairment via the gut-brain axis; supports the mechanistic chain: iron overload → dysbiosis → altered tryptophan metabolism → cognitive effects.

7. Zhang Q, Ding H, Yu X, et al. Plasma non-transferrin-bound iron uptake by the small intestine leads to intestinal injury and intestinal flora dysbiosis in an iron overload mouse model. Sci China Life Sci. 2023. PMID: 37452897 | DOI: 10.1007/s11427-022-2347-0

   • NTBI damages intestinal epithelium and causes flora dysbiosis; directly relevant to Anthony's elevated transferrin saturation and the iron → gut damage → inflammation → IDO activation chain.

Mitochondria, Kynurenine, and Neuropsychiatric Disorders

8. Tanaka M, Szabó Á, Spekker E, et al. Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan-kynurenine metabolic system. Cells. 2022. DOI: 10.3390/cells11162607 — 151 citations (OpenAlex)
   • Reviews how mitochondrial dysfunction and kynurenine pathway activation converge in neuropsychiatric conditions; quinolinic acid impairs mitochondrial function, creating a vicious cycle with iron-mediated oxidative stress.

Immune Pathway and Tryptophan Metabolism

9. Tanaka M, Tóth F, Polyák H, et al. Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines. 2021. PMID: 34202246 | DOI: 10.3390/biomedicines9070734
   • Comprehensive review of immune regulation of kynurenine pathway enzymes (IDO1, IDO2, TDO, KAT, KMO); relevance to neuroinflammation and neurodevelopmental conditions.

Probiotics and Kynurenine Modulation

10. Yang LL, Stiernborg M, Skott E, et al. Effects of a synbiotic on plasma immune activity markers and short-chain fatty acids in children and adults with ADHD — A randomized controlled trial. Nutrients. 2023. PMID: 36904292 | DOI: 10.3390/nu15051293
    • Synbiotic intervention in ADHD modulated SCFAs and immune markers (gut-brain mediators); reduced comorbid autistic traits — supports probiotics as indirect modulators of the kynurenine pathway via inflammation reduction.

Cross-References

• Iron Overload and NTBI
• Gut-Brain Axis and Neurodevelopment
• Trichotillomania and Neurodevelopmental Links
• Fatigue and Burnout
• Genetic Architecture of AuDHD
• Ceruloplasmin and Ferroxidase Activity
• Action Items and Monitoring Plan